Evidence map›Paper›PMID 41240308›Full record

ReviewSub-cellular biochemistry2026

Unconventional Protein Transport Across the Golgi Ribbon.

Jaakko Saraste, Kristian Prydz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Sub-cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jaakko SarasteDepartment of Biomedicine and Molecular Imaging Center, University of Bergen, Bergen, Norway. jaakko.saraste@uib.no.
Kristian PrydzDepartment of Biosciences, University of Oslo, Oslo, Norway. kristian.prydz@ibv.uio.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to the classical secretory pathway, which involves the transport of endoplasmic reticulum (ER)-derived cargo through the cisternal stacks of the Golgi apparatus, several Golgi-independent transport routes contribute to the delivery of membrane-bound and soluble proteins to the plasma membrane (PM) or the extracellular space. Some of these transport events bypassing the Golgi stacks-collectively referred to as unconventional protein secretion (UcPS)-employ vesicular intermediates. However, the nature of these intermediates and the intracellular pathways utilized by various unconventional cargo are only partly understood. Notably, beyond its role in conventional secretory trafficking at the ER-Golgi interface, the intermediate compartment (IC) has been identified at the crossroads of two distinct vesicular UcPS pathways, participating in the sorting and Golgi-independent trafficking of both ER-synthesized (ER translocation signal-containing) and leaderless cytoplasmic cargo. Additionally, findings indicating that the IC directly interacts with the endocytic recycling system may help clarify how various unconventional cargo proteins reach the cell surface. Given that the central IC elements and recycling endosomes (REs)-defined by the GTPases Rab1 and Rab11, respectively-are closely associated with, and may even link the Golgi stacks, this chapter explores the connection between the classical and unconventional secretory routes and their potential divergence at the level of the Golgi ribbon.

Indexed as

Endoplasmic ReticulumGolgi ApparatusAnimalsCell MembraneEndosomesHumansProtein Transportrab GTP-Binding Proteinsrab GTP-Binding ProteinsBrefeldin A (BFA)ER–Golgi intermediate compartment (IC or ERGIC)Golgi bypassGolgi reassembly and stacking proteins (GRASPs or GORASPs)Golgi ribbonRab1Rab11Recycling endosome (RE)Unconventional protein secretion (UcPS)

Identifiers

PMID41240308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.